mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.01 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |